Skip to content

Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial.

Randomized controlled trial · Curr Pharm Des · 2022. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 36043711

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial.

Malaguarnera G, Catania VE, Bertino G et al.
Curr Pharm Des · 2022

PubMed ID
36043711
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.